home / press / releases

Menu
  • Search all tables

releases: https://www.cochran.senate.gov/public/index.cfm/news-releases?ContentRecord_id=c417be13-0071-4cea-871a-9909213470cf

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.cochran.senate.gov/public/index.cfm/news-releases?ContentRecord_id=c417be13-0071-4cea-871a-9909213470cf COCHRAN: PROPOSED NEW REGS COULD JEOPARDIZE DIALYSIS TREATMENTS 2013-11-13 2013 2013-11 Republican House MS Thad Cochran C000567 www.cochran.senate.gov     legacy WASHINGTON, D.C. – U.S. Senator Thad Cochran (R-Miss.) is warning that proposed changes to Medicare reimbursement rates for end-stage renal disease care could jeopardize dialysis treatments for Mississippians, particularly in rural areas where access to care can be limited. Cochran has asked Marilyn Tavenner, administrator of the Centers for Medicare and Medicaid Services (CMS), to consider revising a proposed rule that would effectively undercut reimbursements to dialysis treatment centers throughout the country.  CMS could soon finalize a proposed rule to update and revise the End-Stage Renal Disease (ESRD) prospective payment system for 2014.  The rule could result in a 9.4 percent reduction in payments to ESRD facilities, including the more than 70 certified ESRD facilities in Mississippi. “I’ve heard from dialysis patients in Mississippi who are worried the proposed reductions will affect their treatment, particularly their access to quality care,” said Cochran, a member of the Senate Diabetes Caucus. “Dialysis treatments are vital for many people with diabetes and kidney-related illnesses.  I hope the Centers for Medicare and Medicaid will agree to a more reasonable rule that is fiscally responsible but also fair to dialysis providers,” he said.  The proposed ESRD payment reductions would result in CMS reimbursing most dialysis providers less than the cost of the services they provide.  The average Medicare margin for a dialysis facility is currently about 4 percent, according to the Medicare Payment Advisory Commission, which also recommended that reimbursement rates be held constant. “I request that you consider revising the proposed rule to ensure that funding levels are sufficient to cover the cost of providing life-sustaining treatment to Medicare beneficiaries and to maintain access to quality dialysis care in communities across the country,” Cochran wrote Travenner. Because the Medicare ESRD program currently provides coverage to more than 80 percent of Americans living with ESRD who require dialysis services, Cochran warned that if the proposed rule is finalized “providers will be forced to take steps to reduce costs, which could reduce faculty staffing and limit patients’ flexibility to receive their dialysis treatments.” “In some cases, facility closures could occur, which would significantly reduce patient access to care, particularly in rural communities where access is already a concern.  These cuts would likely have a detrimental impact on dialysis clinics throughout Mississippi and affect many patients receiving dialysis treatment in my state,” Cochran wrote. Cochran, who is the lead Republican cosponsor of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 (S.323), is among 76 Senators who recently wrote in support of continued investment in the Special Diabetes Program, an initiative focused on improving diabetes treatment, prevention and research. LINKS: • CMS ESRD Website: http://go.cms.gov/HPOqCP • Mississippi ESRD Facilities: http://1.usa.gov/17TFuIT • Mississippi State Department of Health Directory of Health Facilities: http://1.usa.gov/1cUQWFR ### 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.83ms · Data license: MIT · Data source: dwillis/congress-press